>
pdufa.bio

Tibulizumab

Updated ยทnext FDA decision on the calendar

Tibulizumab is a Zura Bio Ltd program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

ZURA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Zura Bio Ltd (ZURA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2026ZURA

Questions

When is Tibulizumab's next FDA decision or readout?

The next tracked catalyst for Tibulizumab is a Readout in Nov 2026.

What happened at Tibulizumab's most recent FDA decision?

No FDA decision for Tibulizumab is in our archive yet.

Who makes Tibulizumab?

Zura Bio Ltd (ZURA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.